Tekla Healthcare Investors operates in the Investment offices sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tekla Healthcare Investors with three other
companies in this sector in the United States:
Oxford Lane Capital Corporation
sales of $86.36 million
of which 100%
Blackrock Municipal 2030 Target Term Trust
Calamos Convertible & Hi Income Fund
Tekla Healthcare Investors reported sales of $85.93 million
September of 2019.
increase of 12.7%
versus 2018, when the company's sales were $76.25 million.
Despite this increase, sales are still
below the level achieved in 2017, when Tekla Healthcare Investors
reported sales of $86.68 million.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Tekla Healthcare Investors had sales
of $94.49 million.